FCMI
WVE icon

Foresite Capital Management III’s Wave Life Sciences WVE Stock Holding History

Foresite Capital Management III’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-139,900
Closed -$3.65M – 17
2019
Q2 		$3.65M Sell
139,900
-25,000
-15% -$701K 1.2% 16
2019
Q1 		$6.41M Buy
164,900
+114,900
+230% +$4.66M 1.67% 14
2018
Q4 		$2.1M Hold
50,000
– – 0.69% 20
2018
Q3 		$2.5M Sell
50,000
-25,000
-33% -$1.13M 0.55% 21
2018
Q2 		$2.87M Hold
75,000
– – 0.62% 21
2018
Q1 		$3.01M Sell
75,000
-87,347
-54% -$3.67M 0.66% 16
2017
Q4 		$5.7M Sell
162,347
-700,980
-81% -$20.4M 1.6% 12
2017
Q3 		$18.8M Sell
863,327
-140,773
-14% -$2.83M 5.17% 7
2017
Q2 		$18.7M Buy
1,004,100
+327,972
+49% +$7.07M 6.1% 6
2017
Q1 		$18.6M Hold
676,128
– – 7.14% 5
2016
Q4 		$17.7M Sell
676,128
-51,368
-7% -$1.67M 7.68% 5
2016
Q3 		$23.6M Sell
727,496
-242,608
-25% -$5.73M 11.04% 3
2016
Q2 		$20.1M Sell
970,104
-441,645
-31% -$6.88M 13.77% 3
2016
Q1 		$17.9M Buy
1,411,749
+1,060
+0.1% +$14.8K 13.81% 2
2015
Q4 		$22.5M Buy
+1,410,689
New +$22.1M 19.95% 1

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Foresite Capital Management III's WVE Position: Q3 2019 in Review

Foresite Capital Management III sold out of Wave Life Sciences (WVE) in Q3 2019, closing a stake of 139,900 shares — an estimated $3.65M sold.

Foresite Capital Management III first reported a position in WVE in Q4 2015 and held it in 15 quarters. The position peaked at $23.6M in Q3 2016. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2019.

  • Foresite Capital Management III reported no remaining Wave Life Sciences position as of Q3 2019 after selling out during the quarter.
  • Foresite Capital Management III sold 139,900 Wave Life Sciences shares in Q3 2019, an estimated $3.65M.
  • Foresite Capital Management III first reported a position in Wave Life Sciences in Q4 2015 and held it in 15 quarters.
  • Foresite Capital Management III's Wave Life Sciences position peaked at $23.6M in Q3 2016.
  • 88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2019.

Based on Foresite Capital Management III's 13F filing for Q3 2019, filed 13 Nov 2019.